Another success for hepatitis a vaccine

New England Journal of Medicine

Volumn 357, Issue 17, 2007, Pages 1757-1759

  Baker, Carol J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; IMMUNOGLOBULIN;

CHRONIC LIVER DISEASE; CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEPATITIS A; HUMAN; IMMUNIZATION; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME; VIRUS TRANSMISSION;

EID: 35548941853     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe078189     Document Type: Editorial

References (7)

1. Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55(RR-7):1-23.
2. Reported cases of notifiable diseases, by geographic division and area - United States, 2006. MMWR Morb Mortal Wkly Rep 2007;56:853-63:Table 2.
3. Wheeler C, Vogt TM, Armstrong GL, et al. An outbreak of hepatitis A associated with green onions. N Engl J Med 2005;353:890-7.
4. Update: prevention of hepatitis A after exposure to hepatitis A virus and in international travelers: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep (in press).
5. Robertson BH, D'Hondt EH, Spelbring J, Tian H, Krawczynski K, Margolis HS. Effect of postexposure vaccination in a chimpanzee model of hepatitis A virus infection. J Med Virol 1994;43:249-51.
6. Sagliocca L, Amoroso P, Stroffolini T, et al. Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial. Lancet 1999;353:1136-9. [Erratum, Lancet 1999;353:2078.]
7. Victor JC, Monto AS, Surdina TY, et al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 2007;357:1685-94.